About this trial
This study intends to conduct a retrospective and prospective study on children with hyperthyroidism, and it is a non-intervention study to collect information on diagnosis and treatment and long-term follow-up of children with hyperthyroidism. To investigate the clinical characteristics, treatment effect, side effects and remission of hyperthyroidism in children, to analyze the predictive factors for the effect of antithyroid drug treatment, remission and recurrence after drug withdrawal, and to explore the risk factors related to the occurrence of antithyroid drug-related adverse reactions.
Eligibility criteria
Qualifiers
Age ≤14 years old
Initial diagnosis of hyperthyroidism
Disqualifiers
Hyperthyroidism had been treated with medication in other hospitals,
History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation,
Patients with incomplete clinical data
Trial design
Treatments tested in this trial
- Methimazole(MMI)